A study to evaluate the effect of repeat oral doses of odiparcil on cardiac conduction as assessed by 12-lead electrocardiogram compared to placebo and a single oral dose of moxifloxacin.
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Moxifloxacin; Odiparcil
- Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Embolism and thrombosis; Intra-abdominal infections; Respiratory tract infections; Skin and soft tissue infections; Tuberculosis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 23 Mar 2007 New trial record.